Related Experiment Video
Updated: May 28, 2026

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Published on: February 23, 2024
Death receptor signalling in central nervous system inflammation and demyelination
Conor Mc Guire1, Rudi Beyaert, Geert van Loo
1Department for Molecular Biomedical Research, Unit of Molecular Signal Transduction in Inflammation, VIB, B-9052 Ghent, Belgium.
Abstract:
Death receptors (DRs) are members of the tumor necrosis factor receptor (TNF-R) superfamily that are characterised by the presence of a conserved intracellular death domain and are able to trigger a signalling pathway leading to apoptosis. Strong evidence suggests that DRs contribute to the pathology of tissue destructive diseases, including multiple sclerosis (MS), the most common inflammatory demyelinating disease of the central nervous system (CNS). Here, we review the evidence supporting a role for DRs in MS pathology and its implications for the development of therapeutic strategies for MS and other demyelinating pathologies of the CNS.
Insights
Death receptors (DRs) trigger apoptosis and contribute to tissue-damaging diseases like multiple sclerosis (MS). Understanding DRs in MS pathology could lead to new therapies for CNS demyelinating diseases.
Area of Science:
- Immunology
- Neuroscience
- Cell Biology
Background:
- Death receptors (DRs) are part of the TNF-R superfamily with intracellular death domains.
- DRs initiate signaling pathways that lead to programmed cell death (apoptosis).
- DRs are implicated in the pathology of various tissue-destructive diseases.
Purpose of the Study:
- To review evidence linking DRs to the pathology of multiple sclerosis (MS).
- To discuss the implications of DRs in MS for developing novel therapeutic strategies.
- To explore the role of DRs in other central nervous system (CNS) demyelinating diseases.
Main Methods:
- Literature review of existing research on DRs and MS.
- Analysis of studies investigating DR signaling in CNS inflammation.
- Synthesis of evidence connecting DRs to demyelination and neurodegeneration.
Main Results:
- DRs play a significant role in the inflammatory processes underlying MS.
- Evidence supports DR involvement in the apoptosis of myelin-producing cells (oligodendrocytes).
- DR signaling pathways are potential targets for therapeutic intervention in MS.
Conclusions:
- DRs are key contributors to the pathogenesis of multiple sclerosis.
- Targeting DRs offers a promising avenue for developing treatments for MS and related CNS demyelinating disorders.
More Related Videos
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation
The Extrinsic Apoptotic Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Encephalitis ll: Pathophysiology